IP Library Granted Patent US 11,565,041
Granted Patent B2
US 11,565,041 · App. 17/685,170 · Granted Jan 31, 2023

Ambulatory medicament device with power saving mode

Inventors: Himanshu Patel (Rancho Santa Margarita, CA); Justin P. Brown (Tustin, CA)
Assignee: Beta Bionics, Inc.
A61M5/16831A61B5/002A61B5/0004A61B5/14532A61B5/7405A61B5/746A61B5/7435A61B5/7455A61B5/7475A61M5/14244A61M5/16877A61M5/1723G06F3/04166G06F3/04883G06F3/16G08B21/02G08B21/182G08B23/00G08B25/016A61B2560/0209A61M2005/14208A61M2005/16863A61M2205/18A61M2205/3331A61M2205/502A61M2205/505A61M2205/8212A61M2230/201A61M2230/63G06F2203/04808
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,565,041
App. No.
17/685,170
Granted
Jan 31, 2023
Kind
B2
Abstract

Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.

Claims (89)

1. An ambulatory medicament device configured to display critical status information in a power saving mode, the ambulatory medicament device comprising:

a monitoring system interface configured to receive status information, wherein the status information comprises at least one of device information pertaining to a condition of the ambulatory medicament device or subject information pertaining to a condition of a subject;

a touchscreen controller configured to output display signals configured to generate user interface screens on a touchscreen and to receive user input signals corresponding to user input on the touchscreen, wherein the touchscreen is configured to be illuminated by a backlight;

an accelerometer configured to detect user interaction with the ambulatory medicament device and output user interaction signals corresponding to the user interaction with the ambulatory medicament device, wherein user interaction with the ambulatory medicament device comprises a single tap or a double tap on the ambulatory medicament device;

a memory configured to store specific computer-executable instructions; and

a hardware processor in communication with the memory and configured to execute the specific computer-executable instructions to at least:

receive the user input signals via the touchscreen controller;

receive the user interaction signals via the accelerometer;

activate a power saving mode of the ambulatory medicament device after a period of inactivity or in response to a request to activate the power saving mode, wherein the period of inactivity comprises the hardware processor not receiving a user input signal or a user interaction signal for a predetermined period of time, wherein the touchscreen controller is configured to not receive the user input signals when the ambulatory medicament device is in the power saving mode;

turn off the backlight;

receive the status information via the monitoring system interface;

determine critical status information from the status information;

generate a display of a critical status information interface screen on the touchscreen; and

display on the critical status information interface screen at least one critical status indicator selected from a plurality of critical status indicators corresponding to the critical status information,

wherein the plurality of critical status indicators comprises:

a glucose level indicator of the subject,

a battery level indicator of the ambulatory medicament device,

a therapy status indicator,

a remaining medicament level indicator, and

an alarm status indicator.

2. The ambulatory medicament device of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to determine that a power level of a battery of the ambulatory medicament device is below a predetermined power level threshold and in response to determining that the power level of the battery of the ambulatory medicament device is below the predetermined power level threshold, the hardware processor is further configured to execute the specific computer-executable instructions to:

generate a display of a battery status interface screen; and

display on the battery status interface screen a battery charging indicator to prioritize displaying the status information corresponding to the power level being below the predetermined power level threshold.

3. The ambulatory medicament device of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to determine whether a glucose level of the subject is within a predetermined glucose range and in response to determining that the glucose level is not within the predetermined glucose range, the hardware processor is further configured to execute the specific computer-executable instructions to:

generate a display of a glucose interface screen; and

display on the glucose interface screen the glucose level indicator to prioritize displaying the status information corresponding to the glucose level not being within the predetermined glucose range.

4. The ambulatory medicament device of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to display on the critical status information interface screen an alarm state icon comprising a visual indication of a count of alarm conditions.

5. The ambulatory medicament device of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

activate a privacy mode in response to a request to activate the privacy mode;

generate a display of a privacy mode interface screen; and

display on the privacy mode interface screen one or more status indicators corresponding to the status information without displaying at least one of the plurality of critical status indicators.

6. The ambulatory medicament device of claim 5 , wherein the at least one of the plurality of critical status indicators not displayed comprises at least one of the glucose level indicator of the subject or the therapy status indicator.

7. The ambulatory medicament device of claim 5 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to turn off the touchscreen while in the privacy mode.

8. The ambulatory medicament device of claim 5 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to activate the privacy mode while activating the power saving mode.

9. The ambulatory medicament device of claim 5 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to receive the request to activate the privacy mode interface screen while in the power saving mode.

10. The ambulatory medicament device of claim 5 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to receive the request to activate the privacy mode interface screen while not in the power saving mode.

11. The ambulatory medicament device of any of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

determine that the user interaction signals correspond to a single tap on the ambulatory medicament device; and

in response to determining that the user interaction corresponds to the single tap on the ambulatory medicament device, turn off the touchscreen.

12. The ambulatory medicament device of claim 11 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

determine that the user interaction signals correspond to an other single tap on the ambulatory medicament device; and

in response to determining that the user interaction corresponds to the other single tap on the ambulatory medicament device, turn on the touchscreen while remaining in the power saving mode.

13. The ambulatory medicament device of any of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

determine that the user interaction signals correspond to a double tap on the ambulatory medicament device; and

in response to determining that the user interaction corresponds to the double tap on the ambulatory medicament device, turn on the backlight while remaining in the power saving mode.

14. The ambulatory medicament device of claim 13 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

determine that the user interaction signals correspond to an other double tap on the ambulatory medicament device; and

in response to determining that the user interaction corresponds to the other double tap on the ambulatory medicament device, turn off the backlight while remaining in the power saving mode.

15. The ambulatory medicament device of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

determine that the user interaction signals correspond to a single tap or a double tap on the ambulatory medicament device; and

in response to determining that the user interaction corresponds to the single tap or the double tap on the ambulatory medicament device, deactivate the power saving mode.

16. The ambulatory medicament device of claim 1 , wherein the hardware processor further is configured to execute the specific computer-executable instructions to update the critical status information interface screen in the power saving mode less frequently than updating the user interface screens in a wake mode of the ambulatory medicament device.

17. The ambulatory medicament device of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

receive a request to activate a wake mode of the ambulatory medicament device; and

in response to receiving the request to activate the wake mode, deactivate the power saving mode.

18. The ambulatory medicament device of claim 17 , wherein in response to receiving the request to activate the wake mode, the hardware processor is further configured to execute the specific computer-executable instructions to:

determine that the request to activate the wake mode was received during a predefined period of time; and

in response to determining that the request was received during the predefined period of time, turn on the backlight.

19. The ambulatory medicament device of claim 17 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to receive a wake request signal corresponding to user request on a wake interface of the ambulatory medicament device to active the wake mode.

20. The ambulatory medicament device of claim 1 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to lower a refresh rate of the touchscreen to a lower refresh rate relative to a maximum refresh rate of touchscreen.

21. The ambulatory medicament device of claim 1 , wherein the status information is received from a sensor that measures at least one of a characteristic of the ambulatory medicament device or a physiological parameter of the subject.

22. The ambulatory medicament device of claim 21 further comprising a touchscreen controller configured to output display signals configured to generate user interface screens on the touchscreen and to receive user input signals corresponding to user input on the touchscreen, wherein the touchscreen is configured to be illuminated by the backlight;

wherein the period of inactivity comprises the hardware processor not receiving a user input signal for the predetermined period of time, and wherein the touchscreen controller is configured to not receive the user input signals when the ambulatory medicament device is in the power saving mode.

23. The ambulatory medicament device of claim 21 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

activate a privacy mode in response to a request to activate the privacy mode;

generate a display of a privacy mode interface screen; and

display on the privacy mode interface screen one or more status indicators corresponding to the status information without displaying at least one of the plurality of critical status indicators.

24. The ambulatory medicament device of claim 21 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to:

receive a request to activate a wake mode of the ambulatory medicament device; and

in response to receiving the request to activate the wake mode, deactivate the power saving mode.

25. The ambulatory medicament device of claim 21 , wherein the hardware processor is further configured to execute the specific computer-executable instructions to display on the critical status information interface screen an alarm state icon comprising a visual indication of a count of alarm conditions.

26. The ambulatory medicament device of claim 1 , wherein the hardware processor is configured to execute further computer-executable instructions to lower brightness of the touchscreen of the ambulatory medicament device to a lower brightness level relative to a full brightness level of the touchscreen.

27. The ambulatory medicament device of claim 1 , wherein the ambulatory medicament device comprises a bi-hormonal pump capable of administering insulin and a counter-regulatory agent.

28. The ambulatory medicament device of claim 5 , wherein the touchscreen comprises a filter configured to have a predetermined viewing angle range relative to the touchscreen such that information cannot be seen on the touchscreen when viewed from an angle outside of the predetermined viewing angle range.

29. The ambulatory medicament device of claim 5 , wherein in the power saving mode, the ambulatory medicament device displays the critical status information interface screen by using 5-10% additional electric current relative to electric current used with the touchscreen turned off while the ambulatory medicament device is operating.

30. An ambulatory medicament device configured to display critical status information in a power saving mode, the ambulatory medicament device comprising:

a monitoring system interface configured to receive status information, wherein the status information comprises at least one of device information pertaining to a condition of the ambulatory medicament device or subject information pertaining to a condition of a subject;

a motion sensor configured to detect user interaction with the ambulatory medicament device and output user interaction signals corresponding to the user interaction with the ambulatory medicament device, wherein user interaction with the ambulatory medicament device comprises a single tap or a double tap on the ambulatory medicament device;

a memory configured to store specific computer-executable instructions; and

a hardware processor in communication with the memory and configured to execute the specific computer-executable instructions to at least:

receive the user interaction signals via the motion sensor;

activate a power saving mode of the ambulatory medicament device after a period of inactivity or in response to a request to activate the power saving mode, wherein the period of inactivity comprises the hardware processor not receiving a user interaction signal for a predetermined period of time;

turn off a backlight of the ambulatory medicament device configured to illuminate a touchscreen of the ambulatory medicament device;

receive the status information via the monitoring system interface;

determine critical status information from the status information;

generate a display of a critical status information interface screen on the touchscreen; and

display on the critical status information interface screen at least one of a plurality of critical status indicators corresponding to the critical status information, wherein the plurality of critical status indicators comprises:

a medicament device status indicator, and

a subject status indicator.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2022
From: PATEL, HIMANSHU; BROWN, JUSTIN P.
To: BETA BIONICS, INC.
Reel/Frame 061380/0632 →
Continuity (25)
Continuation PCTUS2021064228 · Dec 17, 2021
Continuation In Part PCTUS2021072742 · Dec 3, 2021
Provisional Application 63128428 · Dec 21, 2020
Provisional Application 63167563 · Mar 29, 2021
Provisional Application 63216177 · Jun 29, 2021
Provisional Application 63239365 · Aug 31, 2021
Provisional Application 63169112 · Mar 31, 2021
Provisional Application 63151565 · Feb 19, 2021
Provisional Application 63261290 · Sep 16, 2021
Provisional Application 63152744 · Feb 23, 2021
Provisional Application 63157541 · Mar 5, 2021
Provisional Application 63152716 · Feb 23, 2021
Provisional Application 63168203 · Mar 30, 2021
Provisional Application 63212521 · Jun 18, 2021
Provisional Application 63139210 · Jan 19, 2021
Provisional Application 63238670 · Aug 30, 2021
Provisional Application 63276481 · Nov 5, 2021
Provisional Application 63215857 · Jun 28, 2021
Provisional Application 63183900 · May 4, 2021
Provisional Application 63249975 · Sep 29, 2021
Provisional Application 63194126 · May 27, 2021
Provisional Application 63263602 · Nov 5, 2021
Provisional Application 63264645 · Nov 29, 2021
Provisional Application 63122427 · Dec 7, 2020
Related Publication 20220265928A1 · Aug 25, 2022